Pulse Biosciences, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
Pulse Biosciences, Inc. (PLSE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 1.13 million shares for the 9-month period ending 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2021-11-15
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-09-30 was 152.26K shares.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-06-30 was 367.26K shares.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2021-03-31 was 608.82K shares.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2020-12-31 was 40.25K shares.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2020 was 1.97M shares, a 69.77% increase from fiscal 2019.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2019 was 1.16M shares, a 76.86% increase from fiscal 2018.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2018 was 657.38K shares, a 57.67% decline from fiscal 2017.
- Pulse Biosciences, Inc. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2017 was 1.55M shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2021-09-30 | 152.26K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-15 | 519.52K shares derived: sum of 2 quarters · filed 2021-11-15 | 1.13M shares 10-Q · filed 2021-11-15 | 1.17M shares derived: sum of 4 quarters · filed 2021-11-15 |
| 2021-06-30 | 367.26K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | 976.08K shares 10-Q · filed 2021-08-09 | 1.02M shares derived: sum of 3 quarters · filed 2021-08-09 | |
| 2021-03-31 | 608.82K shares 10-Q · filed 2021-05-10 | 649.07K shares derived: sum of 2 quarters · filed 2021-05-10 | ||
| 2020-12-31 | 40.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | 1.97M shares 10-K · filed 2021-03-12 | ||
| 2020-09-30 | 1.93M shares 10-Q · filed 2020-11-09 | |||
| 2019-12-31 | 1.16M shares 10-K · filed 2020-03-16 | |||
| 2018-12-31 | 657.38K shares 10-K · filed 2019-03-14 | |||
| 2017-12-31 | 1.55M shares 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |